6
NEWS
Hello Happy
Bob
Diabetes tech startup Harald AI
has launched the popular Happy
Bob App in Europe and in Canada,
giving more ways for users of
Dexcom Continuous Glucose
Monitoring (CGM) Systems to
engage with their diabetes data.
Happy Bob users can view
their glucose values by glancing
at their Apple Watch or iPhone
widget, create groups for support,
collect stars and receive time
sensitive information and push
notifications. Users can also
see their historical data in the
app for longer than 24 hours,
access the expanded view, see
insights on their desktop, and
laugh at the in-app personalized
messaging, alleviating the
stress of daily management and
glycemic control.
The Happy Bob App is now
available for download from the
Apple App Store and Google Play
Store for Dexcom CGM users
in the UK, Europe, Canada and
the USA.
New chair of ABCD
ABCD (Diabetes Care) Ltd have announced that the new Chair of ABCD will
be Professor Ketan Dhatariya, who will take over from Dr Dipesh Patel in
June 2023.
Prof Dhatariya has been a full time NHS consultant since 2004 and is
currently the Chair of both the Joint British Diabetes Societies Inpatient
Care Group and the Examining Board for the UK Specialist Clinical Exam
in Diabetes and Endocrinology. He was also formerly the President of the
Diabetes and Endocrine Section of the Royal Society of Medicine. Prof
Dhatariya joined ABCD as a member in 2004 and has been a committee
member for nine years.
HCL for young people
An NHS England study in children and young people has shown
improvements in glycaemic control, time in range, frequency of
hypoglycaemia, hypoglycaemia fear and quality of sleep for children and
young people when using hybrid closed-loop (HCL) systems for six months.
Hypoglycaemia fear and quality of sleep were also improved for their parents
and carers.
HCL systems are characterised by integrating continuous glucose
monitoring (CGM) with insulin pumps that automate insulin delivery via
specific algorithms and user-initiated insulin delivery. The three HCL
systems used in the study of 251 children and young people were the Tandem
Control-IQ AP system, the Medtronic MiniMed 780G and the CamAPS app.
In addition, the NHS is currently reporting that approximately eight in
10 people now have access to continuous glucose monitoring devices, with
nearly two-thirds of local NHS areas already offering the devices to patients,
and the NHS is aiming for all areas to be offering both continuous glucose
monitors and flash monitors in 2023.
Harvard expert
Beta Bionics has hired Steven Russell as chief medical officer. The change
comes as Beta Bionics works to secure US Food and Drug Administration
(FDA) clearance for its pocket-sized, wearable autonomous insulin dosing
device, iLet.
Russell joined Massachusetts General Hospital in 2001 and has held the
role of attending physician for most of his time at the organization. Russell
also worked from 2006 at Harvard Medical School, where he spent the past
five years as associate professor of medicine. Russell has kept his Harvard
faculty appointment and will work at MGH Diabetes Associates part time.
Beta Bionics designed iLet to enable
users to enter their body weight and
leave the device to titrate and infuse
insulin. The company claims that the
device outperformed a standard of
care control arm that included
people using hybrid closed loop
systems in its pivotal trial.